M. E. Vega-Villegas

EPIC: Phase III Trial of Cetuximab Plus Irinotecan After Fluoropyrimidine and Oxaliplatin Failure in Patients With Metastatic Colorectal Cancer

Alberto Sobrero, Joan Maurel, Louis Fehrenbacher et al. · Journal of Clinical Oncology · 2008 · 945 citations · Full text

Cetuximab in metastatic or recurrent head and neck cancer: the EXTREME trial

Fernando Rivera, Almudena García‐Castaño, N. Bello Vega et al. · Expert Review of Anticancer Therapy · 2009 · 125 citations

Neck Cancer, Radiation Therapy, Medicine +15

Cetuximab administered once every second week to patients with metastatic colorectal cancer: a two-part pharmacokinetic/pharmacodynamic phase I dose-escalation study

Josep Tabernero, Fortunato Ciardiello, Fernando Rivera et al. · Annals of Oncology · 2009 · 90 citations · Full text

Dose-escalation Study, Oncology, Gastrointestinal Oncology +7

A Phase II study of preoperative radiotherapy and concomitant weekly irinotecan in combination with protracted venous infusion 5-fluorouracil, for resectable locally advanced rectal cancer

Matilde Navarro, E. Dotor, Fernando Rivera et al. · International Journal of Radiation Oncology*Biology*Physics · 2006 · 69 citations

Surgical Oncology, Radiation Therapy, Medicine +8

Phase II Trial of Preoperative Irinotecan–Cisplatin Followed by Concurrent Irinotecan–Cisplatin and Radiotherapy for Resectable Locally Advanced Gastric and Esophagogastric Junction Adenocarcinoma

Fernando Rivera, Maica Galán, Josep Tabernero et al. · International Journal of Radiation Oncology*Biology*Physics · 2009 · 35 citations

Surgical Oncology, Phase Ii Trial, Radiation Therapy +8